Home › Funds › Yelin Lapidot Holdings Management Ltd. › MDWD

Yelin Lapidot Holdings Management Ltd. position in MDWD

MEDIWOUND LTD · Health Care

Yelin Lapidot Holdings Management Ltd. reported holding 758,169 shares of MDWD (MEDIWOUND LTD) in its Q3 2026 13F filing — a position valued at US$10.4M, representing 1.90% of its reported portfolio and ranking #11 among its reported holdings. Yelin Lapidot Holdings Management Ltd. has disclosed MDWD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)758.17K sh
Reported value held$10.44M
Portfolio Weight1.90%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Yelin Lapidot Holdings Management Ltd.'s MDWD position evolved

Yelin Lapidot Holdings Management Ltd. first disclosed a stake in MDWD in Q3 2023 at 86,145 shares (US$936K). The position peaked in Q2 2025 at 816,741 shares, worth US$15.8M. Across 13 filings, Yelin Lapidot Holdings Management Ltd. increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 758,169 shares valued at US$10.4M. Notable position changes include a 46% increase in Q4 2023 (shares rose 40% over the following quarter), a 129% increase in Q1 2024 (shares rose 9% over the following quarter), a 161% increase in Q3 2024 (shares fell 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 86.14K $936.40K New
Q4 2023 125.49K $1.28M Add
Q1 2024 287.83K $4.10M Add
Q2 2024 287.83K $4.47M Hold
Q3 2024 750.74K $13.56M Add
Q4 2024 851.36K $15.15M Add
Q1 2025 858.00K $13.32M Add
Q2 2025 816.74K $15.82M Reduce
Q3 2025 809.95K $14.60M Reduce
Q4 2025 763.07K $14.09M Reduce
Q1 2026 762.82K $12.29M Hold
Q2 2026 758.17K $11.15M Reduce
Q3 2026 758.17K $10.44M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDWD and 13F data

MDWD (MEDIWOUND LTD) is a Health Care company. 26 other funds we track also report a position in MDWD — the largest reported positions include INVESTOR AB (US$12.8M), Rosalind Advisors, Inc. (US$11.0M), Silverberg Bernstein Capital Management LLC (US$3.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDWD

All MDWD fund holders →

FAQ

How long has Yelin Lapidot Holdings Management Ltd. held MDWD?

Yelin Lapidot Holdings Management Ltd. has disclosed MDWD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Yelin Lapidot Holdings Management Ltd.'s current position in MDWD?

As of Q3 2026, Yelin Lapidot Holdings Management Ltd. holds 758.17K shares of MDWD (MEDIWOUND LTD), valued at $10.44M, representing 1.90% of its reported portfolio and ranking #11.

Has Yelin Lapidot Holdings Management Ltd. been buying or selling MDWD?

In the latest 13F filing (Q3 2026), Yelin Lapidot Holdings Management Ltd. held unchanged its position in MDWD. The position peaked in Q2 2025 at 816.74K shares.

Which other funds hold MDWD?

Other major institutional holders of MDWD include INVESTOR AB, Rosalind Advisors, Inc., Silverberg Bernstein Capital Management LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.